94 related articles for article (PubMed ID: 12725506)
21. The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia.
Jardine A; Menzies RI; Deeks SL; Patel MS; McIntyre PB
Pediatr Infect Dis J; 2009 Sep; 28(9):761-5. PubMed ID: 19546840
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of hospitalization for acute lower respiratory tract infection among Australian indigenous infants 5-23 months of age following pneumococcal vaccination: a cohort study.
O'Grady KA; Lee KJ; Carlin JB; Torzillo PJ; Chang AB; Mulholland EK; Lambert SB; Andrews RM
Clin Infect Dis; 2010 Apr; 50(7):970-8. PubMed ID: 20192729
[TBL] [Abstract][Full Text] [Related]
23. Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia?
Giele C; Moore H; Bayley K; Harrison C; Murphy D; Rooney K; Keil AD; Lehmann D
Vaccine; 2007 Mar; 25(13):2379-84. PubMed ID: 17064825
[TBL] [Abstract][Full Text] [Related]
24. Prevention of pneumococcal disease through vaccination.
Gentile A; Bazán V
Vaccine; 2011 Sep; 29 Suppl 3():C15-25. PubMed ID: 21896348
[TBL] [Abstract][Full Text] [Related]
25. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
Hsu KK; Shea KM; Stevenson AE; Pelton SI;
Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
[TBL] [Abstract][Full Text] [Related]
26. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
[TBL] [Abstract][Full Text] [Related]
28. Invasive pneumococcal disease in Australia, 2002.
Roche P; Krause V; Andrews R; Carter L; Coleman D; Cook H; Counahan M; Giele C; Gilmore R; Hart S; Pugh R; Hogg G; Murphy D; Watson M;
Commun Dis Intell Q Rep; 2003; 27(4):466-77. PubMed ID: 15508500
[TBL] [Abstract][Full Text] [Related]
29. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
[TBL] [Abstract][Full Text] [Related]
30. Invasive pneumococcal disease in north Queensland, 2001.
Hills SL; Hanna JN; Murphy D
Commun Dis Intell Q Rep; 2002; 26(4):520-4. PubMed ID: 12549517
[TBL] [Abstract][Full Text] [Related]
31. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
32. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
[TBL] [Abstract][Full Text] [Related]
33. The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia--over 22 years.
Jacups SP; Cheng A
Vaccine; 2011 Jul; 29(33):5386-92. PubMed ID: 21651943
[TBL] [Abstract][Full Text] [Related]
34. Pneumococcal meningitis in Western Australian children: epidemiology, microbiology and outcome.
King BA; Richmond P
J Paediatr Child Health; 2004 Nov; 40(11):611-5. PubMed ID: 15469529
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterisation of pneumococcal serotype 16F: Established predominant carriage and otitis media serotype in the 7vPCV era.
Marsh RL; Smith-Vaughan H; Beissbarth J; Hare K; Kennedy M; Wigger C; Mellon G; Stubbs E; Gadil JR; Pettit A; Mackenzie G; Tipakalippa P; Morris PS; Leach AJ
Vaccine; 2007 Mar; 25(13):2434-6. PubMed ID: 17028080
[TBL] [Abstract][Full Text] [Related]
37. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A
Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190
[TBL] [Abstract][Full Text] [Related]
38. Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.
Leal J; Vanderkooi OG; Church DL; Macdonald J; Tyrrell GJ; Kellner JD
Pediatr Infect Dis J; 2012 Sep; 31(9):e169-75. PubMed ID: 22673137
[TBL] [Abstract][Full Text] [Related]
39. Pneumococcal vaccination.
de Roux A; Lode H
Eur Respir J; 2005 Dec; 26(6):982-3. PubMed ID: 16319323
[No Abstract] [Full Text] [Related]
40. Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010.
Thoon KC; Chong CY; Tee NW
Int J Infect Dis; 2012 Mar; 16(3):e209-15. PubMed ID: 22281191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
